Leerink Upgrades Replimune Group (REPL) to Outperform

August 4, 2026 3:43 AM

Leerink analyst Daina Graybosch upgraded Replimune Group (NASDAQ: REPL) from Market Perform to Outperform with a price target of $17.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found